256 related articles for article (PubMed ID: 1581912)
21. Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation.
Salmon A; Amikam D; Sodha N; Davidson S; Basel-Vanagaite L; Eeles RA; Abeliovich D; Peretz T
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):490-3. PubMed ID: 17572079
[TBL] [Abstract][Full Text] [Related]
22. Balanced t(11;15)(q23;q15) in a TP53+/+ breast cancer patient from a Li-Fraumeni syndrome family.
Sherif ZA; Danielsen M
Cancer Genet Cytogenet; 2006 Jul; 168(1):50-8. PubMed ID: 16772121
[TBL] [Abstract][Full Text] [Related]
23. p53 mosaicism with an exon 8 germline mutation in the founder of a cancer-prone pedigree.
Kovar H; Auinger A; Jug G; Müller T; Pillwein K
Oncogene; 1992 Nov; 7(11):2169-73. PubMed ID: 1359493
[TBL] [Abstract][Full Text] [Related]
24. Follow-up study of twenty-four families with Li-Fraumeni syndrome.
Garber JE; Goldstein AM; Kantor AF; Dreyfus MG; Fraumeni JF; Li FP
Cancer Res; 1991 Nov; 51(22):6094-7. PubMed ID: 1933872
[TBL] [Abstract][Full Text] [Related]
25. [Germline mutations of the p53 gene].
Frebourg T
Pathol Biol (Paris); 1997 Dec; 45(10):845-51. PubMed ID: 9769948
[TBL] [Abstract][Full Text] [Related]
26. Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family.
Stolzenberg MC; Brugières L; Gardes M; Dessarps-Freichey F; Chompret A; Bressac B; Lenoir G; Bonaïti-Pellié C; Lemerle J; Feunteun J
Oncogene; 1994 Oct; 9(10):2799-804. PubMed ID: 8084585
[TBL] [Abstract][Full Text] [Related]
27. p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies.
Pötzsch C; Voigtländer T; Lübbert M
J Cancer Res Clin Oncol; 2002 Aug; 128(8):456-60. PubMed ID: 12200603
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population.
Yamada H; Shinmura K; Okudela K; Goto M; Suzuki M; Kuriki K; Tsuneyoshi T; Sugimura H
Carcinogenesis; 2007 Sep; 28(9):2013-8. PubMed ID: 17690113
[TBL] [Abstract][Full Text] [Related]
29. Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer.
Brugières L; Gardes M; Moutou C; Chompret A; Meresse V; Martin A; Poisson N; Flamant F; Bonaïti-Pellié C; Lemerle J
Cancer Res; 1993 Feb; 53(3):452-5. PubMed ID: 8425176
[TBL] [Abstract][Full Text] [Related]
30. Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer.
Jolly KW; Malkin D; Douglass EC; Brown TF; Sinclair AE; Look AT
Oncogene; 1994 Jan; 9(1):97-102. PubMed ID: 8302608
[TBL] [Abstract][Full Text] [Related]
31. Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil.
Palmero EI; Schüler-Faccini L; Caleffi M; Achatz MI; Olivier M; Martel-Planche G; Marcel V; Aguiar E; Giacomazzi J; Ewald IP; Giugliani R; Hainaut P; Ashton-Prolla P
Cancer Lett; 2008 Mar; 261(1):21-5. PubMed ID: 18248785
[TBL] [Abstract][Full Text] [Related]
32. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.
Plummer SJ; Santibáñez-Koref M; Kurosaki T; Liao S; Noble B; Fain PR; Anton-Culver H; Casey G
Oncogene; 1994 Nov; 9(11):3273-80. PubMed ID: 7936651
[TBL] [Abstract][Full Text] [Related]
33. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.
Srivastava S; Zou ZQ; Pirollo K; Blattner W; Chang EH
Nature; 1990 Dec 20-27; 348(6303):747-9. PubMed ID: 2259385
[TBL] [Abstract][Full Text] [Related]
34. Screening for germline p53 mutations in pediatric and adult patients of high-risk groups in Poland.
Fiszer-Maliszewska L; Czernik J; Sawicz-Birkowska K; Perek D; Kozera M; Wojciechowska B; Kazanowska B; Hudziec P; Kilar E
Arch Immunol Ther Exp (Warsz); 2000; 48(4):309-15. PubMed ID: 11059649
[TBL] [Abstract][Full Text] [Related]
35. Absence of significant germ line p53 mutations in ovarian cancer patients.
Buller RE; Skilling JS; Kaliszewski S; Niemann T; Anderson B
Gynecol Oncol; 1995 Sep; 58(3):368-74. PubMed ID: 7672703
[TBL] [Abstract][Full Text] [Related]
36. Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites.
Rapakko K; Allinen M; Syrjäkoski K; Vahteristo P; Huusko P; Vähäkangas K; Eerola H; Kainu T; Kallioniemi OP; Nevanlinna H; Winqvist R
Br J Cancer; 2001 Jan; 84(1):116-9. PubMed ID: 11139324
[TBL] [Abstract][Full Text] [Related]
37. Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families.
Manoukian S; Peissel B; Pensotti V; Barile M; Cortesi L; Stacchiotti S; Terenziani M; Barbera F; Pasquini G; Frigerio S; Pierotti MA; Radice P; Della-Torre G
Eur J Cancer; 2007 Feb; 43(3):601-6. PubMed ID: 17224268
[TBL] [Abstract][Full Text] [Related]
38. p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome.
Quesnel S; Verselis S; Portwine C; Garber J; White M; Feunteun J; Malkin D; Li FP
Oncogene; 1999 Jul; 18(27):3970-8. PubMed ID: 10435620
[TBL] [Abstract][Full Text] [Related]
39. BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.
Lalloo F; Varley J; Moran A; Ellis D; O'dair L; Pharoah P; Antoniou A; Hartley R; Shenton A; Seal S; Bulman B; Howell A; Evans DG
Eur J Cancer; 2006 May; 42(8):1143-50. PubMed ID: 16644204
[TBL] [Abstract][Full Text] [Related]
40. [Hereditary mutations in the p53 tumor suppressor gene; significance for clinical practice. National Work Group Hereditary Mamma Carcinoma].
Menko FH; Nooy MA; Vasen HF
Ned Tijdschr Geneeskd; 1996 Jun; 140(26):1347-50. PubMed ID: 8710022
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]